The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR’s COVID-19 Vaccine Clinical Guidance Summary v5

The ACR’s COVID-19 Vaccine Clinical Guidance Summary v5

March 21, 2022 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

On Feb. 2, 2022, the ACR released a revised version of its COVID-19 Vaccine Clinical Guidance Summary (version 5, revised). A full paper was originally published online in Arthritis & Rheumatology (A&R) on March 17, 2021, and version 5 has been submitted to A&R for publication. Updates include:

You Might Also Like
  • ACR Releases COVID-19 Clinical Guidance for Pediatric Patients
  • Join the ACR COVID-19 Clinical Guidance Town Hall: May 6
  • Guidance Coming for Anticipated COVID-19 Vaccine
Also By This Author
  • The Physician Leader and Management
  • Recommendations differentiating supplemental and booster doses, including timing considerations; and
  • Guidance on pre- and post-exposure prophylaxis with monoclonal antibody treatment, considering updated EUAs.

This document is intended to provide guidance to rheumatology providers on the use of the COVID-19 vaccine and the associated management of rheumatic and musculoskeletal disease patients around the time of vaccination against SARS-CoV-2. These statements were based upon a dearth of high-quality data and are not intended to replace clinical judgment. Modifications made to treatment plans, particularly in complex rheumatic disease patients, are highly disease, patient, geography and time specific and, therefore, must be individualized as part of a shared decision-making process. This guidance is provided as part of a living document, recognizing rapidly evolving evidence and the anticipated need for frequent updates. The target audience for this guidance is providers and patients in the U.S., although the ACR recognizes that people outside of the U.S. may read and use the information provided here.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Visit the ACR website for updates: https://www.rheumatology.org/Practice-Quality/Clinical-Support/COVID-19-Guidance

Notes

  1. Refer to Table 2 in the Guidance Summary: https://tinyurl.com/2p2amm4h
  2. Refer to Table 3 in the Guidance Summary: https://tinyurl.com/2p2amm4h

Recommendations Tables

Table 1. Click to enlarge.

Table 2. Click to enlarge.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Filed Under: Conditions, From the College, Guidelines Tagged With: COVID-19

You Might Also Like:
  • ACR Releases COVID-19 Clinical Guidance for Pediatric Patients
  • Join the ACR COVID-19 Clinical Guidance Town Hall: May 6
  • Guidance Coming for Anticipated COVID-19 Vaccine
  • ACR Releases COVID-19 Clinical Guidance for Pediatric Patients with Rheumatic Disease

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.